Ultragenyx Pharmaceutical

+$4.17 (+3.91%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell RARE and other stocks, options, and ETFs commission-free!

About RARE

Ultragenyx Pharmaceutical Inc. Common Stock, also called Ultragenyx Pharmaceutical, is a biopharmaceutical company, which engages in the identification, acquisition, development and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases.

CEO
Emil D. Kakkis
Employees
893
Headquarters
Novato, California
Founded
2010

RARE Key Statistics

Market Cap
7.61B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
557.14K
High Today
$111.85
Low Today
$106.76
Open Price
$108.08
Volume
281.32K
52 Week High
$179.65
52 Week Low
$63.94

RARE Earnings

-$2.05
-$1.49
-$0.93
-$0.37
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$1.24 per share
Actual
-$2.03 per share
Replay Earnings Call

You May Also Like

HLI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure